Hans Moebius
2023
In 2023, Hans Moebius earned a total compensation of $1.3M as Former Chief Medical Officer at Athira Pharma, a 39% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $172,050 |
|---|---|
| Option Awards | $531,999 |
| Salary | $465,000 |
| Other | $123,424 |
| Total | $1,292,474 |
Moebius received $532K in option awards, accounting for 41% of the total pay in 2023.
Moebius also received $172.1K in non-equity incentive plan, $465K in salary and $123.4K in other compensation.
Rankings
In 2023, Hans Moebius' compensation ranked 940th out of 3,006 executives tracked by ExecPay. In other words, Moebius earned more than 68.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 940 out of 3,006 | 69th |
Division Manufacturing | 555 out of 1,650 | 66th |
Major group Chemicals And Allied Products | 378 out of 918 | 59th |
Industry group Drugs | 367 out of 881 | 58th |
Industry Biological Products, Except Diagnostic Substances | 113 out of 213 | 47th |
Source: SEC filing on April 9, 2024.
Moebius' colleagues
We found two more compensation records of executives who worked with Hans Moebius at Athira Pharma in 2023.